Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy

According to the analysis on locally advanced breast cancer (LABC) from all breast cancer cases recorded in Surveillance Epidemiology and End Results database between the years 1992 - 1999 in the United States, the incidence of LABC were found to be 4,6 % of all female breast cancers. Clinically, wh...

Full description

Saved in:
Bibliographic Details
Published in:Experimental Oncology
Date:2013
Main Author: Yalcin, B.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2013
Subjects:
Online Access:https://nasplib.isofts.kiev.ua/handle/123456789/145234
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy / B. Yalcin // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 250-252. — Бібліогр.: 23 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
_version_ 1862599475361480704
author Yalcin, B.
author_facet Yalcin, B.
citation_txt Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy / B. Yalcin // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 250-252. — Бібліогр.: 23 назв. — англ.
collection DSpace DC
container_title Experimental Oncology
description According to the analysis on locally advanced breast cancer (LABC) from all breast cancer cases recorded in Surveillance Epidemiology and End Results database between the years 1992 - 1999 in the United States, the incidence of LABC were found to be 4,6 % of all female breast cancers. Clinically, when breast cancer has advanced locoregionally but has not yet spread outside of the breast and regional lymph nodes, it is considered LABC. LABC includes breast cancers that have evidence of a large mass, involve the skin of the breast or the underlying muscles of the chest wall, and cancers that have infiltrated into the local lymph nodes. The prognosis of patients with LABC is relatively poor, with 5-year survival rates less than 50 %. Because the incidence of LABC is very low, there are not many studies comparing neoadjuvant chemotherapy regimens in the literature. In management of LABC, initial therapy should be systemic neoadjuvant chemotherapy, aiming pCR. Anthracycline-based chemotherapy regimens are frequently recommended as the standard primary neoadjuvant chemotherapy for the treatment of LABC. Today the optimal duration of neoadjuvant chemotherapy is unknown. Neoadjuvant endocrine therapy is considered an option for patients with honnone receptor-positive LABC. Ongoing clinical trials are now under way to evaluate the use of novel targeted agents in the neoadjuvant treatment of LABC.
first_indexed 2025-11-27T22:40:41Z
format Article
fulltext
id nasplib_isofts_kiev_ua-123456789-145234
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
issn 1812-9269
language English
last_indexed 2025-11-27T22:40:41Z
publishDate 2013
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
record_format dspace
spelling Yalcin, B.
2019-01-19T17:42:43Z
2019-01-19T17:42:43Z
2013
Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy / B. Yalcin // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 250-252. — Бібліогр.: 23 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/145234
According to the analysis on locally advanced breast cancer (LABC) from all breast cancer cases recorded in Surveillance Epidemiology and End Results database between the years 1992 - 1999 in the United States, the incidence of LABC were found to be 4,6 % of all female breast cancers. Clinically, when breast cancer has advanced locoregionally but has not yet spread outside of the breast and regional lymph nodes, it is considered LABC. LABC includes breast cancers that have evidence of a large mass, involve the skin of the breast or the underlying muscles of the chest wall, and cancers that have infiltrated into the local lymph nodes. The prognosis of patients with LABC is relatively poor, with 5-year survival rates less than 50 %. Because the incidence of LABC is very low, there are not many studies comparing neoadjuvant chemotherapy regimens in the literature. In management of LABC, initial therapy should be systemic neoadjuvant chemotherapy, aiming pCR. Anthracycline-based chemotherapy regimens are frequently recommended as the standard primary neoadjuvant chemotherapy for the treatment of LABC. Today the optimal duration of neoadjuvant chemotherapy is unknown. Neoadjuvant endocrine therapy is considered an option for patients with honnone receptor-positive LABC. Ongoing clinical trials are now under way to evaluate the use of novel targeted agents in the neoadjuvant treatment of LABC.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Special issue on breast cancer
Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
Article
published earlier
spellingShingle Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
Yalcin, B.
Special issue on breast cancer
title Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
title_full Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
title_fullStr Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
title_full_unstemmed Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
title_short Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
title_sort overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
topic Special issue on breast cancer
topic_facet Special issue on breast cancer
url https://nasplib.isofts.kiev.ua/handle/123456789/145234
work_keys_str_mv AT yalcinb overviewonlocallyadvancedbreastcancerdefiningepidemiologyandoverviewonneoadjuvanttherapy